UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders

Molecular psychiatry, 2020-06, Vol.25 (6), p.1275-1285

2020

Link zum Volltext

Verfügbarkeit prüfen

A Spastic Paraplegic Syndrome of Obscure Etiology

Neurology India, 2020-03, Vol.68 (2), p.264-267

2020

Link zum Volltext

Verfügbarkeit prüfen

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.95

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease

Journal of Alzheimer's disease, 2021-01, Vol.82 (s1), p.S91

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.223

2011

Link zum Volltext

Verfügbarkeit prüfen

DEF8 and Autophagy-Associated Genes Are Altered in Mild Cognitive Impairment, Probable Alzheimer's Disease Patients, and a Transgenic Model of the Disease

Journal of Alzheimer's disease, 2021-01, Vol.82 (s1), p.S163

2021

Link zum Volltext

Verfügbarkeit prüfen

Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.17

2011

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychiatric Symptoms Among Hispanics: Results of the Maracaibo Aging Study

Journal of Alzheimer's disease, 2021-01, Vol.82 (s1), p.S251

2021

Link zum Volltext

Verfügbarkeit prüfen

Total Plasma Homocysteine and Depressive Symptoms in Older Hispanics

Journal of Alzheimer's disease, 2021-01, Vol.82 (s1), p.S263

2021

Link zum Volltext

Verfügbarkeit prüfen

A new hope for neurodegeneration: possible role of hydrogen sulfide

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.173

2011

Link zum Volltext

Verfügbarkeit prüfen

Amyloid clearance as a treatment target against Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.61

2011

Link zum Volltext

Verfügbarkeit prüfen

Tau transgenic mice as models for cerebrospinal fluid tau biomarkers

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.127

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of advanced glycation on aggregation and DNA binding properties of α-synuclein

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.211

2011

Link zum Volltext

Verfügbarkeit prüfen

Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.1

2011

Link zum Volltext

Verfügbarkeit prüfen

BACE1 as a potential biomarker for Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.53

2011

Link zum Volltext

Verfügbarkeit prüfen

Oxidative stress treatment for clinical trials in neurodegenerative diseases

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.111

2011

Link zum Volltext

Verfügbarkeit prüfen

Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.75

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.199

2011

Link zum Volltext

Verfügbarkeit prüfen

Modulating Alzheimer's disease through caffeine: a putative link to epigenetics

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.161

2011

Link zum Volltext

Verfügbarkeit prüfen

When will Alzheimer's disease be cured? A pharmaceutical perspective

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.43

Townsend, Matthew

2011

Link zum Volltext

Verfügbarkeit prüfen

Cognitive aging and early diagnosis challenges in Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.153

2011

Link zum Volltext

Verfügbarkeit prüfen

A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.5

2011

Link zum Volltext

Verfügbarkeit prüfen

Humanin signal for Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.27

Matsuoka, Masaaki

2011

Link zum Volltext

Verfügbarkeit prüfen

Membrane anchored and lipid raft targeted β-secretase inhibitors for Alzheimer's disease therapy

Journal of Alzheimer's disease, 2011-01, Vol.24 Suppl 2, p.143

2011

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotection and Neuroregeneration in Alzheimer's Disease

International journal of alzheimer's disease, 2012, Vol.2012, p.864138-1

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(5)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders

A Spastic Paraplegic Syndrome of Obscure Etiology

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases

Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease

Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide

DEF8 and Autophagy-Associated Genes Are Altered in Mild Cognitive Impairment, Probable Alzheimer's Disease Patients, and a Transgenic Model of the Disease

Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease

Neuropsychiatric Symptoms Among Hispanics: Results of the Maracaibo Aging Study

Total Plasma Homocysteine and Depressive Symptoms in Older Hispanics

A new hope for neurodegeneration: possible role of hydrogen sulfide

Amyloid clearance as a treatment target against Alzheimer's disease

Tau transgenic mice as models for cerebrospinal fluid tau biomarkers

Role of advanced glycation on aggregation and DNA binding properties of α-synuclein

Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease

BACE1 as a potential biomarker for Alzheimer's disease

Oxidative stress treatment for clinical trials in neurodegenerative diseases

Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease

Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy

Modulating Alzheimer's disease through caffeine: a putative link to epigenetics

When will Alzheimer's disease be cured? A pharmaceutical perspective

Cognitive aging and early diagnosis challenges in Alzheimer's disease

A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease

Humanin signal for Alzheimer's disease

Membrane anchored and lipid raft targeted β-secretase inhibitors for Alzheimer's disease therapy

Neuroprotection and Neuroregeneration in Alzheimer's Disease

Aktive Filter

Suchergebnisse filtern